Baker-Bros-Advisors-Lp

AI_NATIVE detailed information: This accession holds the following tickers:[
  "MRUS",
  "AKRO",
  "KNSA",
  "EWTX",
  "CNTA",
  "ALKS",
  "INSM",
  "RVMD",
  "ARGX",
  "ACAD",
  "MDGL",
  "ABCL",
  "PRME",
  "SKYE",
  "TCRX",
  "RCKT",
  "BCAX",
  "BCYC",
  "GPCR",
  "IMTX",
  "RLAY",
  "IGMS",
  "TSHA",
  "TYRA",
  "NRIX",
  "STOK",
  "ACRV",
  "SMMT",
  "TECX",
  "KYMR",
  "REPL",
  "NMRA",
  "GLUE",
  "NGNE",
  "TSVT",
  "ALMS",
  "ALGS",
  "CTNM",
  null,
  "FATE",
  "SANA",
  null,
  "KALA",
  "LPTX",
  "PRLD",
  "SGMT",
  "IONS",
  "TARA",
  null,
  "IDYA",
  "INCY",
  "SERA",
  "PRAX",
  "RGLS",
  "RYTM",
  "NTLA",
  "DYN",
  null,
  "GRAL",
  "WVE",
  "ROIV",
  "OPT",
  "ELVN",
  "GBIO",
  "IMCR",
  "HOOK",
  "DSGN",
  "KOD",
  "VRNA",
  "VERV",
  "VIR",
  "VTVT",
  "XENE",
  "TRDA",
  "XNCR",
  "RARE",
  "IMVT",
  "PCVX",
  null,
  "BNTX",
  "CADL",
  "CELC",
  "CLDX",
  "CERS",
  "IPSC",
  "CMPX",
  "CRSP",
  "DNLI",
  "IRON"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 89
Total Value: 9036702464
Accession Number: 0001104659-25-049518
Form Type: 13F-HR
CIK: baker-bros-advisors-lp
Manager Name: Baker-Bros-Advisors-Lp

Data Enrichment

94% identified

84 identified5 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

89 positions • $9.0B total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 4 of 5

Sort by:

Celldex Therapeutics, Inc.

CLDX|15117B202

Shares:247.6K

Value:$4.5M

% of Portfolio:0.0% ($4.5M/$9.0B)

829401108

Shares:400.0K

Value:$4.2M

% of Portfolio:0.0% ($4.2M/$9.0B)

BioNTech SE

BNTX|09075V102

Shares:45.0K

Value:$4.1M

% of Portfolio:0.0% ($4.1M/$9.0B)

TScan Therapeutics, Inc.

TCRX|89854M101

Shares:2.8M

Value:$3.8M

% of Portfolio:0.0% ($3.8M/$9.0B)

Disc Medicine, Inc.

IRON|254604101

Shares:77.0K

Value:$3.8M

% of Portfolio:0.0% ($3.8M/$9.0B)

Vir Biotechnology, Inc.

VIR|92764N102

Shares:542.5K

Value:$3.5M

% of Portfolio:0.0% ($3.5M/$9.0B)

Sana Biotechnology, Inc.

SANA|799566104

Shares:2.0M

Value:$3.4M

% of Portfolio:0.0% ($3.4M/$9.0B)

Sagimet Biosciences Inc.

SGMT|786700104

Shares:953.0K

Value:$3.1M

% of Portfolio:0.0% ($3.1M/$9.0B)

Relay Therapeutics, Inc.

RLAY|75943R102

Shares:1.2M

Value:$3.0M

% of Portfolio:0.0% ($3.0M/$9.0B)

Wave Life Sciences Ltd.

WVE|Y95308105

Shares:344.1K

Value:$2.8M

% of Portfolio:0.0% ($2.8M/$9.0B)

FATE THERAPEUTICS INC

FATE|31189P102

Shares:3.3M

Value:$2.6M

% of Portfolio:0.0% ($2.6M/$9.0B)

Skye Bioscience, Inc.

SKYE|83086J200

Shares:1.5M

Value:$2.3M

% of Portfolio:0.0% ($2.3M/$9.0B)

Protara Therapeutics, Inc.

TARA|74365U107

Shares:536.8K

Value:$2.3M

% of Portfolio:0.0% ($2.3M/$9.0B)

Enliven Therapeutics, Inc.

ELVN|29337E102

Shares:114.8K

Value:$2.3M

% of Portfolio:0.0% ($2.3M/$9.0B)

Contineum Therapeutics, Inc.

CTNM|21217B100

Shares:312.5K

Value:$2.2M

% of Portfolio:0.0% ($2.2M/$9.0B)

Prime Medicine, Inc.

PRME|74168J101

Shares:1.0M

Value:$2.0M

% of Portfolio:0.0% ($2.0M/$9.0B)

Tectonic Therapeutic, Inc.

TECX|878972108

Shares:100.0K

Value:$1.8M

% of Portfolio:0.0% ($1.8M/$9.0B)

vTv Therapeutics Inc.

VTVT|918385204

Shares:97.3K

Value:$1.7M

% of Portfolio:0.0% ($1.7M/$9.0B)

Compass Therapeutics, Inc.

CMPX|20454B104

Shares:547.5K

Value:$1.0M

% of Portfolio:0.0% ($1.0M/$9.0B)

Neumora Therapeutics, Inc.

NMRA|640979100

Shares:1.0M

Value:$1.0M

% of Portfolio:0.0% ($1.0M/$9.0B)

Instrument	Shares		Other Manager	Value	% of Portfolio
Celldex Therapeutics, Inc.(CLDXcusip15117B202)	247.6K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$4.5M	0.0% ($4.5M/$9.0B)	QoQ -28.17% (-$1.8M) YoY -56.75% (-$5.9M)
(cusip829401108)✕	400.0K	QoQ NEW(+400.0K) YoY NEW(+400.0K)	All Managers (Combined)	$4.2M	0.0% ($4.2M/$9.0B)	QoQ NEW(+$4.2M) YoY NEW(+$4.2M)
BioNTech SE(BNTXcusip09075V102)	45.0K	QoQ 0.00% (-0) YoY NEW(+45.0K)	All Managers (Combined)	$4.1M	0.0% ($4.1M/$9.0B)	QoQ -20.08% (-$1.0M) YoY NEW(+$4.1M)
TScan Therapeutics, Inc.(TCRXcusip89854M101)	2.8M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$3.8M	0.0% ($3.8M/$9.0B)	QoQ -54.60% (-$4.6M) YoY -82.61% (-$18.3M)
Disc Medicine, Inc.(IRONcusip254604101)	77.0K	QoQ 0.00% (-0) YoY NEW(+77.0K)	All Managers (Combined)	$3.8M	0.0% ($3.8M/$9.0B)	QoQ -21.70% (-$1.1M) YoY NEW(+$3.8M)
Vir Biotechnology, Inc.(VIRcusip92764N102)	542.5K	QoQ -49.97% (-542.0K) YoY NEW(+542.5K)	All Managers (Combined)	$3.5M	0.0% ($3.5M/$9.0B)	QoQ -55.83% (-$4.4M) YoY NEW(+$3.5M)
Sana Biotechnology, Inc.(SANAcusip799566104)	2.0M	QoQ -14.70% (-350.0K) YoY -14.70% (-350.0K)	All Managers (Combined)	$3.4M	0.0% ($3.4M/$9.0B)	QoQ -12.08% (-$469.0K) YoY -85.66% (-$20.4M)
Sagimet Biosciences Inc.(SGMTcusip786700104)	953.0K	QoQ 0.00% (-0) YoY -31.03% (-428.9K)	All Managers (Combined)	$3.1M	0.0% ($3.1M/$9.0B)	QoQ -27.55% (-$1.2M) YoY -58.52% (-$4.4M)
Relay Therapeutics, Inc.(RLAYcusip75943R102)	1.2M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$3.0M	0.0% ($3.0M/$9.0B)	QoQ -36.40% (-$1.7M) YoY -68.43% (-$6.6M)
Wave Life Sciences Ltd.(WVEcusipY95308105)	344.1K	QoQ 0.00% (-0) YoY NEW(+344.1K)	All Managers (Combined)	$2.8M	0.0% ($2.8M/$9.0B)	QoQ -34.68% (-$1.5M) YoY NEW(+$2.8M)
FATE THERAPEUTICS INC(FATEcusip31189P102)	3.3M	QoQ 0.00% (-0) YoY +79.21% (-1.4M)	All Managers (Combined)	$2.6M	0.0% ($2.6M/$9.0B)	QoQ -52.11% (-$2.8M) YoY -80.70% (-$10.8M)
Skye Bioscience, Inc.(SKYEcusip83086J200)	1.5M	QoQ 0.00% (-0) YoY NEW(+1.5M)	All Managers (Combined)	$2.3M	0.0% ($2.3M/$9.0B)	QoQ -43.81% (-$1.8M) YoY NEW(+$2.3M)
Protara Therapeutics, Inc.(TARAcusip74365U107)	536.8K	QoQ 0.00% (-0) YoY +168.85% (+337.2K)	All Managers (Combined)	$2.3M	0.0% ($2.3M/$9.0B)	QoQ -19.31% (-$547.6K) YoY +185.61% (+$1.5M)
Enliven Therapeutics, Inc.(ELVNcusip29337E102)	114.8K	QoQ 0.00% (-0) YoY 0.00% (+0)	All Managers (Combined)	$2.3M	0.0% ($2.3M/$9.0B)	QoQ -12.53% (-$323.8K) YoY +11.88% (+$240.0K)
Contineum Therapeutics, Inc.(CTNMcusip21217B100)	312.5K	QoQ 0.00% (-0) YoY NEW(+312.5K)	All Managers (Combined)	$2.2M	0.0% ($2.2M/$9.0B)	QoQ -52.35% (-$2.4M) YoY NEW(+$2.2M)
Prime Medicine, Inc.(PRMEcusip74168J101)	1.0M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$2.0M	0.0% ($2.0M/$9.0B)	QoQ -31.84% (-$956.5K) YoY -71.57% (-$5.2M)
Tectonic Therapeutic, Inc.(TECXcusip878972108)	100.0K	QoQ NEW(+100.0K) YoY NEW(+100.0K)	All Managers (Combined)	$1.8M	0.0% ($1.8M/$9.0B)	QoQ NEW(+$1.8M) YoY NEW(+$1.8M)
vTv Therapeutics Inc.(VTVTcusip918385204)	97.3K	QoQ 0.00% (+0) YoY 0.00% (-0)	All Managers (Combined)	$1.7M	0.0% ($1.7M/$9.0B)	QoQ +25.42% (+$341.7K) YoY -26.39% (-$604.3K)
Compass Therapeutics, Inc.(CMPXcusip20454B104)	547.5K	QoQ -64.85% (-1.0M) YoY -64.85% (-1.0M)	All Managers (Combined)	$1.0M	0.0% ($1.0M/$9.0B)	QoQ -53.94% (-$1.2M) YoY -66.27% (-$2.0M)
Neumora Therapeutics, Inc.(NMRAcusip640979100)	1.0M	QoQ 0.00% (-0) YoY +63.22% (-400.7K)	All Managers (Combined)	$1.0M	0.0% ($1.0M/$9.0B)	QoQ -90.56% (-$9.9M) YoY -88.12% (-$7.7M)